Cannabidiol (CBD) in Fragile X syndrome (FXS) and Autism Spectrum disorder (ASD)


Who has not heard about the healing properties of CBD (cannabidiol) lately?

CBD is a non-mind altering plant-based substance that targets the brain’s endocannabinoid system, which regulates behavior. Recent studies suggest that treatments targeting this system could help people with Fragile X syndrome or autism. This study will test CBD treatment in male and female Fragile X mice to learn whether gender affects the response to CDB treatment. This could pave the way for CBD as a behavior-regulating treatment for Fragile X.

Learn more about the grant at:

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.

To learn more about FRAXA’s Fragile X syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit

Let’s Connect

Articles You May Like

Cannabis for Beginners – What is THC?
Idaho bans CBD, other hemp products for animals, saying they’re ‘adulterated’
Momentum builds in Hawaii for legalization for recreational marijuana
New research questions medical marijuana’s impact
Arkansans mixed on recreational marijuana legalization

Leave a Reply

Your email address will not be published.